Biosimilars
Q. What are ‘biosilmilars’?- Published on 14 Mar 16a. Biopharmaceutical drug similar to previously licensed one
b. A clone of living thing
c. Drugs which help in curing the same disease/symptoms
d. Drugs obtained from same biological source like same microorganisms.
ANSWER: Biopharmaceutical drug similar to previously licensed one
- Biosimilars is a biopharmaceutical drug designed to have active properties similar to one that has previously been licensed.
- Only minor differences in clinically inactive components are allowable in biosimilar products.
- Biosimilars are officially approved versions of original "innovator" products, and can be manufactured when the original product's patent expires. Reference to the innovator product is an integral component of the approval.
